Pomanda estimates the enterprise value of PYRAMID PHARMA 9 LTD at £0 based on a Turnover of £0 and 0.32x industry multiple (adjusted for size and gross margin).
pyramid pharma 9 ltdEstimated Valuation
£0
Pomanda estimates the enterprise value of PYRAMID PHARMA 9 LTD at £0 based on an EBITDA of £0 and a 3.53x industry multiple (adjusted for size and gross margin).
pyramid pharma 9 ltdEstimated Valuation
£1
Pomanda estimates the enterprise value of PYRAMID PHARMA 9 LTD at £1 based on Net Assets of £1 and 1.98x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pyramid Pharma 9 LtdOverview
Pyramid Pharma 9 Ltd is a live company located in london, NW11 8EL with a Companies House number of 14541703. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in December 2022, it's largest shareholder is
sqmoujza limited
with a 29.2% stake. Pyramid Pharma 9 Ltd is a startup,
unknown sized company, Pomanda has estimated its turnover at
£0 with
unknown
growth in recent years.
There is insufficient data available to calculate a health check for Pyramid Pharma 9 Ltd. Company Health Check FAQs
Health Rating0out of 5
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Pyramid Pharma 9 Ltd
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Pyramid Pharma 9 Ltd
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Pyramid Pharma 9 Ltd
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Pyramid Pharma 9 Ltd
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Pyramid Pharma 9 Ltd
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Pyramid Pharma 9 Ltd
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- - Pyramid Pharma 9 Ltd
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Pyramid Pharma 9 Ltd
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Pyramid Pharma 9 Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Pyramid Pharma 9 Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pyramid Pharma 9 Ltd
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Pyramid Pharma 9 Ltd
- - Industry AVG
PYRAMID PHARMA 9 LTD financials
EXPORT
Pyramid Pharma 9 Ltd's latest turnover from December 2023 is estimated at 0 and the company has net assets of £1. According to their latest financial statements, we estimate that Pyramid Pharma 9 Ltd has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Turnover
Other Income Or Grants
Cost Of Sales
Gross Profit
Admin Expenses
Operating Profit
Interest Payable
Interest Receivable
Pre-Tax Profit
Tax
Profit After Tax
Dividends Paid
Retained Profit
Employee Costs
Number Of Employees
EBITDA*
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Tangible Assets
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
Stock & work in progress
Trade Debtors
Group Debtors
Misc Debtors
1
Cash
misc current assets
total current assets
1
total assets
1
Bank overdraft
Bank loan
Trade Creditors
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
net assets
1
total shareholders funds
1
Dec 2023
Operating Activities
Operating Profit
Depreciation
Amortisation
Tax
Stock
Debtors
1
Creditors
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations
-1
Investing Activities
capital expenditure
Change in Investments
cash flow from investments
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
1
interest
cash flow from financing
1
cash and cash equivalents
cash
overdraft
change in cash
pyramid pharma 9 ltd Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for pyramid pharma 9 ltd. Get real-time insights into pyramid pharma 9 ltd's credit score, group structure and payment trends.
Perform a competitor analysis for pyramid pharma 9 ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other startup companies, companies in NW11 area or any other competitors across 12 key performance metrics.
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pyramid pharma 9 ltd.
pyramid pharma 9 ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PYRAMID PHARMA 9 LTD. This can take several minutes, an email will notify you when this has completed.
pyramid pharma 9 ltdCompanies House Filings - See Documents
